505(b)2 and Drug Approval Pathways

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/e3/13/9f/e3139fd4-9846-e8c7-facb-2aced8440d8c/mza_4466492584645592940.jpg/600x600bb.jpg

WSPA Ambulatory Care Academy Podcast

WA State Pharmacy Assoc

10 episodes

5 months ago

This Podcast is designed for pharmacy professionals working in and passionate about Ambulatory Care Academies.

Medicine

Health & Fitness

RSS

All content for WSPA Ambulatory Care Academy Podcast is the property of WA State Pharmacy Assoc and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

This Podcast is designed for pharmacy professionals working in and passionate about Ambulatory Care Academies.

Medicine

Health & Fitness

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/55c280351cdda4514e10b39878444226.jpg

505(b)2 and Drug Approval Pathways

WSPA Ambulatory Care Academy Podcast

27 minutes

9 months ago

505(b)2 and Drug Approval Pathways

Join us for another episode of the Ambulatory Care Academy Podcast where we have an insightful discussion with Darell Connor, AmCA student representative, Doctor of Pharmacy Candidate 2025 from Creighton University and Pharmacy Corporate Project Manager with the American Oncology Network. In this AmCA Podcast, Darell discusses the 505(b)2 drug approval pathways and its impacts. Drug approval has evolved, and how patients may eventually get medications has expanded beyond "FDA drug approval". Listen in as we converse with Darell and learn how the 505(b)2 pathway will impact ambulatory care pharmacy.